WU Meng-ling, SONG Yao-hong. Anti-apoptosis Effect of Astragaloside on Isoproterenol-induced Rat Primary Cardiomyocytes[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(10): 137-143.
DOI:
WU Meng-ling, SONG Yao-hong. Anti-apoptosis Effect of Astragaloside on Isoproterenol-induced Rat Primary Cardiomyocytes[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(10): 137-143. DOI: 10.13422/j.cnki.syfjx.20181035.
Anti-apoptosis Effect of Astragaloside on Isoproterenol-induced Rat Primary Cardiomyocytes
Objective: To study the anti-apoptosis effect of astragaloside Ⅳ on isoproterenol-induced rat primary myocardial cell injury. Method: Enzymatic lysis and differential velocity adherent technique were used to isolate primary myocardial cellsfrom postnatal heart of 1-3-day-old normal SD rats
inoculate them in 24 aperture planks and cultured for 48 h in vitro. Normal group
model group
metoprolol group and low
medium and high-dose astragaloside Ⅳ groups were set up. Isoprenaline (ISO) was given to cause heart failure in vitro
except for normal group. After 30 min
the corresponding concentrations of metoprolol (2.336 μg·L-1) and astragaloside Ⅳ (low dose 3 μmol·L-1
middle dose 10 μmol·L-1
high dose 30 μmol·L-1) were given to the treatment groups. The total protein content was determined with BCA method
the expressions of B cell lymphoma/lewkmia-2 (Bcl-2)
Bcl-2 associated X protein (Bax) and Bcl-2 associated K protein (Bak) in primary cardiomyocytes were detected by Western blot
theapoptosis rate in each group was detected by flow cytometry
and the cell nuclei in each group was observed by Hochest/PI double staining method. Result: Compared with the control group
the vitality of the primary cardiomyocytes in each administration group (10-40 μmol·L-1) was up-regulated (P<0.05). Hochest-PI double staining showed that compared with the model group
metoprolol group
and middle and high-dose astragaloside Ⅳ groupsshowed decreases in apoptoticbright blue cells.Flow cytometry showed that compared with the model group
the apoptosis rate of metoprolol group was down-regulated (P<0.01)
and the apoptosis rate of medium-dose astragaloside Ⅳ group was down-regulated (P<0.05)
and the apoptosis rate of high-dose astragaloside Ⅳ group was down-regulated (P<0.01). The gray value of Bcl-2 results showed that compared with model group
the expression of Bcl-2 in the metoprolol group was increased (P<0.01)
the expression of Bcl-2 was increased in astragaloside Ⅳ group (P<0.05)
and the expression of Bcl-2 was increased in high-dose astragaloside Ⅳ group (P<0.01). The gray value of Bak showed that compared with model group
the expression of Bak in the metoprolol group was down-regulated (P<0.05)
and the expression of Bak in high-dose astragaloside Ⅳ group was down-regulated (P<0.05). The gray value Bax showed that compared with model group
the expression of Bax in the metoprolol group was down-regulated (P<0.01)
and the expression of Bax in high-dose astragaloside Ⅳ group was down-regulated (P<0.05). Conclusion: Astragaloside Ⅳ has the anti-apoptosis effect on the injury of isoproterenol-induced rat primary cardiomyocytes.
Astragaloside Ⅳ Induces Autophagy and Apoptosis in Nasopharyngeal Carcinoma Cells via PI3K/Akt/mTOR Pathway
Establishment and Evaluation of Mouse Model of Ischemic Heart Disease with Qi and Yin Deficiency Syndrome Based on Proteomics
Treatment of Sepsis-induced Inflammatory Responses with Xijiao Dihuangtang by Modulation of PKM2-mediated One-carbon Metabolism Pathway
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Related Author
LIN Ting
PENG Jiaxin
TAO Yangyang
ZHOU Fangliang
HE Yingchun
ZHANG Qiuyan
LI Ying
GAO Yunxiao
Related Institution
Hunan Provincial Key Laboratory for the Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Traditional Chinese Medicine (TCM),Hunan University of Chinese Medicine
Hunan Provincial Engineering and Technological Research Center for Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Chinese Medicine and Protecting Visual Function, Hunan University of Chinese Medicine
College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine
College of Medicine, Hunan University of Chinese Medicine